Markets

Health Care Sector Update for 06/05/2017: VRNA

Top Health-care stocks:

JNJ: -0.1%

PFE: -0.1%

ABT: +0.1%

MRK: -0.2%

AMGN: +0.6%

Health-care shares were mainly lower in early trade on Monday.

In health-care stocks news, Verona Pharma ( VRNA ) said Monday it has started a clinical pharmacokinetic trial in the United States for its product candidate, RPL554, following the acceptance of an Investigational New Drug application by the U.S. Food and Drug Administration.

Shares in the company were unchanged at $13.50 in early trade. The stock has traded between $11.05 and $17.50 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

VRNA

Other Topics

US Markets